Adipotide

FDA APPROVAL PENDING

Emerging

Weight

Weight

Adipotide

Amino acid sequence

25

Amino acids

2557.2da

Molecular weight

Peptide

Type

Chimeric adipose-vasculature-targeted peptidomimetic targeting prohibitin/annexin A2 on white adipose tissue endothelium, delivering pro-apoptotic D-(KLAKLAK)2 motif. In obese primates it produced rapid fat loss with improved insulin resistance, yet development halted after Phase 1 due to kidney safety signals.

Top researched benefits

Overview of Adipotide

CKGGRAKDC ligand homes to prohibitin/annexin A2 on white-fat endothelium; linked D-(KLAKLAK)2 disrupts mitochondrial membranes post-internalization, triggering localized endothelial apoptosis and adipocyte loss.

Weight Loss

  • Selective white adipose tissue vascular targeting produced 7-15% body-weight loss over 4 weeks in obese macaques.

Metabolic

  • Improved insulin response (reduced insulin AUC) following fat-mass reduction in primates.

Appetite Control

  • Weight loss without primary appetite suppression; peripheral vascular approach.

Storage

Lyophilized: -20°C freezer. Reconstituted: 2-8°C refrigerated

Frequency

Once daily

Typical Dose

0.43 mg/kg

Cycle Duration

28 days

Chemical Makeup

Key benefits

Rapid fat-mass reduction via selective white adipose tissue vascular targeting

Improved insulin sensitivity following adipose reduction

Non-CNS peripheral mechanism distinct from appetite suppressants

Community interest

This peptide is still gaining traction in the community.

Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

Adipotide Molecular Information

View the scientifc details of Adipotide.

25

Amino Acids

Adipotide

Cys

Cys

Position 1

Lys

Lys

Position 2

Gly

Gly

Position 3

Gly

Gly

Position 4

Arg

Arg

Position 5

Ala

Ala

Position 6

Lys

Lys

Position 7

Asp

Asp

Position 8

Cys

Cys

Position 9

Gly

Gly

Position 10

Gly

Gly

Position 11

Lys

Lys

Position 12

Leu

Leu

Position 13

Ala

Ala

Position 14

Lys

Lys

Position 15

Leu

Leu

Position 16

Ala

Ala

Position 17

Lys

Lys

Position 18

Lys

Lys

Position 19

Leu

Leu

Position 20

Ala

Ala

Position 21

Lys

Lys

Position 22

Leu

Leu

Position 23

Ala

Ala

Position 24

Lys

Lys

Position 25

Amino acid sequence
CysteinePosition 1
LysinePosition 2
GlycinePosition 3
GlycinePosition 4
ArgininePosition 5
AlaninePosition 6
LysinePosition 7
Aspartic acidPosition 8
CysteinePosition 9
GlycinePosition 10
GlycinePosition 11
LysinePosition 12
LeucinePosition 13
AlaninePosition 14
LysinePosition 15
LeucinePosition 16
AlaninePosition 17
LysinePosition 18
LysinePosition 19
LeucinePosition 20
AlaninePosition 21
LysinePosition 22
LeucinePosition 23
AlaninePosition 24
LysinePosition 25

Molecular Weight

2557.2Da

Chain Length

25Amino Acids

Type

Peptide

Adipotide Protocols

Rapid fat-mass reduction in obese non-human primates with improved insulin sensitivity; direct white adipose tissue vascular targeting.

GoalDosageFrequencyRoute
Primate Research Replication0.431 week rangeSubQ
Dose-Finding (Research)0.11 week rangeSubQ

Reconstitution Instructions

Materials needed:

Lyophilized peptide vialBacteriostatic water (BAC water)Alcohol swabs & sterile syringesInsulin syringes (0.5-1 mL)

Steps to reconstitute

  1. Sanitize hands and workspace; swab vial septum
  2. Inject BAC water slowly down vial wall; do not jet onto powder
  3. Gently swirl until fully dissolved (do not shake)
  4. Label with concentration/date; store at 2-8°C

Adipotide Cycle

The Adipotide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Early reduction in abdominal circumference
Week 2-4
Progressive weight/fat-mass decline
Week 0-0
Partial rebound possible; lab signals include mild creatinine rise and electrolyte shifts

Dosing tools

Adipotide Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

Adipotide

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Adipotide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
Adipotide
Dosing
0.43 mg/kg
Dosing Frequency
Once daily
Cycle Duration
28 days
Storage
Lyophilized: -20°C freezer. Reconstituted: 2-8°C refrigerated

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Adipotide interactions with other common peptides and substances.

Weight

aod

Metabolic

AOD-9604

MONITOR

No published data on combined use or pharmacodynamic interaction.

MONITOR

Healing

bpc

Longevity

BPC-157

COMPATIBLE

No known direct interaction; distinct mechanisms and targets.

COMPATIBLE

Weight

cag

Metabolic

Cagrilintide

MONITOR

No clinical data on co-administration; mechanisms differ.

MONITOR

Skin

mela

Sexual

Melanotan II

MONITOR

Theoretical vascular/pressor effects; stagger dosing, monitor BP and hydration.

MONITOR

Weight

sem

Metabolic

Semaglutide

MONITOR

Potential additive dehydration/GI effects; monitor renal function.

MONITOR

Weight

tir

Metabolic

Tirzepatide

MONITOR

Overlapping weight-loss effects; monitor kidney function, volume status, electrolytes.

MONITOR

Side effects

Monitor: Be careful when combining Adipotide with AOD-9604, Cagrilintide, Melanotan II, Semaglutide, Tirzepatide.

Contraindications

Pregnancy/lactation (not studied)

Dehydration

Concurrent nephrotoxic medications

Stop signs

Sustained creatinine elevation or oliguria

Progressive electrolyte abnormalities

Severe injection-site reactions or systemic symptoms

Unexpected toxicity

Bad signs

Collapsed/moist cake suggests temperature excursion; do not use without QCCloudiness/precipitate indicates degradation or contamination—discard
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

AdipotideResearch References

Adipotide is an emerging compound

4Research references

Adipotide

Adipotide is an emerging compound

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

Rhesus macaques at 0.43 mg/kg SC daily for 28 days showed 7.4-14.7% weight loss; insulin resistance improved; mild, dose-dependent, reversible proximal tubule changes.

2011

Reversal of obesity by targeted ablation of adipose tissue

Mice with diet-induced obesity showed ~30% weight reduction; adipose vascular apoptosis; metabolic normalization.

2004

Prohibitin/Annexin A2 Interaction Regulates Fatty-Acid Transport

Mechanistic validation of prohibitin/ANXA2 axis in adipose tissue, core to TP01 targeting.

2016

Mixed-Chirality Prohibitin Peptide: D-(RLARLAR)2 Enhances Stability

Next-generation prohibitin constructs improve serum stability and efficacy vs. first-generation TP01.

2025